Page last updated: 2024-12-05

margaric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Margaric acid, also known as heptadecanoic acid, is a saturated fatty acid with the formula CH3(CH2)15COOH. It is a white, waxy solid at room temperature. It is found naturally in small amounts in some animal fats, such as butter and lard. It is not commonly found in vegetable oils. Margaric acid can be synthesized in the laboratory by hydrogenation of oleic acid. Margaric acid is not considered to be an essential fatty acid for humans. It is not known to have any significant biological effects. Margaric acid is not commonly studied, as it is not considered to be an important compound in human health or nutrition. However, it is sometimes used in the production of soaps and cosmetics.'

margaric acid: RN given refers to unlabeled parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

heptadecanoic acid : A C17 saturated fatty acid and trace component of fats in ruminants. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10465
CHEMBL ID1172910
CHEBI ID32365
SCHEMBL ID5941
MeSH IDM0060611

Synonyms (79)

Synonym
63399-94-0
margarinic acid
n-heptadecanoic acid
506-12-7
heptadecanoic acid
margaric acid
nsc-3743
nsc3743
n-heptadecylic acid
wln: qv16
n-heptadecoic acid
nsc 3743
brn 1781004
einecs 208-027-1
ai3-36481
margarinsaeure
c17:0
heptadecylic acid
heptadecoic acid
ch3-[ch2]15-cooh
CHEBI:32365 ,
heptadecanoic acid, >=98%
daturic acid
daturinic acid
LMFA01010017
68424-37-3
8EBAABCC-09B2-43FB-945D-A70E5905BFBE
heptadecanoic acic
H0019
CHEMBL1172910
heptadecansäure
NCGC00260099-01
dsstox_cid_1596
dsstox_rid_78651
dsstox_gsid_28306
tox21_202550
cas-67701-03-5
BBL013181
STL163960
AKOS005716689
nsc 122836
einecs 264-123-3
lead(2+) heptadecanoate
S3336
einecs 266-928-5
ec 266-928-5
ec 270-298-7
einecs 270-298-7
sda 19-005-00
unii-v987y9oz8l
4-02-00-01193 (beilstein handbook reference)
v987y9oz8l ,
FT-0628169
margaric acid [mi]
BP-30092
SCHEMBL5941
normal-heptadecanoic acid
mfcd00002751
DTXSID5021596
heptadecanoic-d33 acid
352431-41-5
heptadecanoic acid, 98%
normal-heptadecanoate
margaroic acid
fa 17:0
CS-W004284
SY010570
HY-W004284
x90 ,
Q902204
margaric'acid
AMY5932
H10748
AS-57021
BP-27918
EN300-19173
A871505
fa 17:0a
Z104473032

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The ratio of HA to PA Cmax and AUC was also calculated and compared."( Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
Barrett, JS; Mascarenhas, MR; Mondick, JT; Schall, JI; Stallings, VA; Wilson, M, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
"2μm) and oil digestibility (corn oil versus mineral oil) on the bioavailability of a model long chain fatty acid (heptadecanoic acid) and lipophilic nutraceutical (Coenzyme Q10) was investigated using a rat feeding study."( Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10.
Cho, HT; Kim, J; McClements, DJ; Park, Y; Salvia-Trujillo, L; Xiao, H, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Combined with a dose-response experiment, which showed that labeled pheromone titer did not increase above an applied concentration of 20 mg/ml, these data suggest that the final step in pheromone biosynthesis, reduction of Z11-16:Acyl-CoA, may be inhibited by increased acyl-CoA titers in the gland."( The fate of topically applied fatty acids in the sex pheromone gland of the moth Heliothis virescens.
Foster, SP, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
mammalian metaboliteAny animal metabolite produced during a metabolic reaction in mammals.
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency5.18880.000221.22318,912.5098AID1259243; AID743035; AID743063
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency29.15840.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.62160.000229.305416,493.5996AID743075
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency5.18520.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (88)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (30.68)18.7374
1990's8 (9.09)18.2507
2000's20 (22.73)29.6817
2010's25 (28.41)24.3611
2020's8 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.99 (24.57)
Research Supply Index4.55 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index65.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (4.44%)5.53%
Reviews5 (5.56%)6.00%
Case Studies1 (1.11%)4.05%
Observational2 (2.22%)0.25%
Other78 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]